VIELA BIO, INC.

Profile

Company Names

VIELA BIO, INC.

Addresses

1 MEDIMMUNE WAY, GAITHERSBURG, MD 20878

Phone Numbers

240-780-6356

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$357,253,240.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-06-12 
$75,000,000.00 
$75,000,000.00 
$0.00 
Equity 
1
2018-02-23 
$282,253,240.00 
$312,253,240.00 
$30,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
YANLING 
 
CAO 
DIRECTOR
LIFEMINE THERAPEUTICS, INC.   |  VIELA BIO, INC.   |  JW (CAYMAN) THERAPEUTICS CO. LTD
YANLING 
(BING) 
CAO 
DIRECTOR
VIELA BIO, INC.
EDWARD 
 
HU 
DIRECTOR
VIVACE THERAPEUTICS, INC.   |  LIFEMINE THERAPEUTICS, INC.   |  IDEAYA BIOSCIENCES, INC.   |  VIELA BIO, INC.
BAHIJA 
(BING) 
JALLAL 
DIRECTOR
VIELA BIO, INC.
TING 
(BING) 
JIA 
DIRECTOR
VIELA BIO, INC.
MATTHEW 
(BING) 
PIETRAS 
EXECUTIVE OFFICER
VIELA BIO, INC.
TYRELL 
 
RIVERS 
DIRECTOR
VIELA BIO, INC.   |  CORVIDIA THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  CERAPEDICS INC   |  NUCLEUS RADIOPHARMA, INC.   |  PATHOS AI, INC.
PASCAL 
 
SORIOT 
DIRECTOR
VIELA BIO, INC.
XIAOMENG 
 
TONG 
DIRECTOR
VIELA BIO, INC.   |  BOYU CAPITAL OFFSHORE FUND   |  BOYU CAPITAL US FUND   |  BOYU CAPITAL OPPORTUNITIES MASTER FUND
XIAOMENG 
(BING) 
TONG 
DIRECTOR
VIELA BIO, INC.
ANDREAS 
 
WICKI 
DIRECTOR
VIELA BIO, INC.
WENKAI 
 
XIANG 
DIRECTOR
VIELA BIO, INC.   |  7G BIOVENTURES I, L.P.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
WENKAI 
(BING) 
XIANG 
DIRECTOR
VIELA BIO, INC.
ZHENGBIN (BING) 
 
YAO 
EXECUTIVE OFFICER, DIRECTOR
VIELA BIO, INC.   |  ARRIVENT BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-06-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-06-12 
2018-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SOLEBURY CAPITAL LLC
14399